Annovis Bio Inc — Quarterly Financial Statistics (NYSE:ANVS) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities -3.2 M-8.29 M-8.1 M-5.11 M-3.49 M -24.98 M Cash from investing activities ————— — Cash from financing activities 11.84 M6.2 M19.78 M01.64 M 27.63 M Free cash flow -3.2 M-8.29 M-8.1 M-5.11 M-3.49 M -24.98 M

뉴스

아노비스 바이오, 2026년 1월 파킨슨병 장기 약물 연구 개시

Annovis Bio to launch long-term Parkinson’s drug study in January

Analysis-Alzheimer’s drug hunt learns from cancer fight’s multi-target playbook

Monday’s Insider Moves: Adverum Execs Lead Buys, Diamondback Sale Tops

Annovis Bio 이사 Hoffman, 193,794달러 상당 주식 매수

Annovis Bio director Hoffman buys $193,794 in shares

Sunday’s Insider Moves: Major Buys at STAA, ANVS While ROIV Sees Selling

아노비스 바이오 이사 Hoffman, ANVS 주식 69.9천 달러 매입

Annovis Bio director Hoffman buys $69.9k in ANVS stock

Annovis Bio Stock Jumps On Heels Of New Parkinson's Data - Annovis Bio (NYSE:ANVS)

Annovis Bio’s phase 3 Alzheimer’s trial reaches 25% completion

Annovis Bio raises $3.4 million in registered direct offering